Plasma ceramides are elevated in female children and adolescents with type 2 diabetes

Journal of Pediatric Endocrinology and Metabolism

Volumn 26, Issue 9-10, 2013, Pages 995-998

  Lopez, Ximena ^a   Goldfine, Allison B ^b   Holland, William L ^a   Gordillo, Ruth ^a   Scherer, Philipp E ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b JOSLIN DIABETES CENTER   (United States)

Author keywords

Adolescents; Ceramides; Children; Insulin resistance; Obesity; Type 2 diabetes

Indexed keywords

ADIPONECTIN; CERAMIDE; GLUCOSYLCERAMIDE; HEMOGLOBIN A1C;

ADOLESCENT; ARTICLE; BODY MASS; CHILD; CHILDHOOD OBESITY; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ETHNICITY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN SENSITIVITY; LIQUID CHROMATOGRAPHY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; RACE; TANDEM MASS SPECTROMETRY; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADIPONECTIN; ADOLESCENT; BIOLOGICAL MARKERS; BODY MASS INDEX; CERAMIDES; CHILD; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DOWN-REGULATION; FEMALE; HUMANS; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; OBESITY; TANDEM MASS SPECTROMETRY; UP-REGULATION;

EID: 84877294515     PISSN: 0334018X     EISSN: 21910251     Source Type: Journal    
DOI: 10.1515/jpem-2012-0407     Document Type: Article

References (12)

1. Holland WL, Summers SA. Sphingolipids, insulin resistance, and metabolic disease: new insights from in vivo manipulation of sphingolipid metabolism. Endocr Rev 2008;29: 381-402.
2. Adams JM 2nd, Pratipanawatr T, Berria R, Wang E, DeFronzo RA, et al. Ceramide content is increased in skeletal muscle from obese insulin-resistant humans. Diabetes 2004;53: 25-31.
3. Holland WL, Bikman BT, Wang LP, Yuguang G, Sargent KM, et al. Lipid-induced insulin resistance mediated by the proinflammatory receptor TLR4 requires saturated fatty acid-induced ceramide biosynthesis in mice. J Clin Invest 2011;121: 1858-70.
4. Schmitz-Peiffer C, Craig DL, Biden TJ. Ceramide generation is sufficient to account for the inhibition of the insulin-stimulated PKB pathway in C2C12 skeletal muscle cells pretreated with palmitate. J Biol Chem 1999;274: 24202-10.
5. Holland WL, Miller RA, Wang ZV, Sun K, Barth BM, et al. Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin. Nat Med 2011;17: 55-63.
6. Haus JM, Kashyap SR, Kasumov T, Zhang R, Kelly KR, et al. Plasma ceramides are elevated in obese subjects with type 2 diabetes and correlate with the severity of insulin resistance. Diabetes 2009;58: 337-43.
7. Błachnio-Zabielska AU, Pułka M, Baranowski M, Nikołajuk A, Zabielski P, et al. Ceramide metabolism is affected by obesity and diabetes in human adipose tissue. J Cell Physiol 2012;227: 550-7.
8. Majumdar I, Mastrandrea LD. Serum sphingolipids and inflammatory mediators in adolescents at risk for metabolic syndrome. Endocrine 2012;41: 442-9.
9. Holland WL, Brozinick JT, Wang LP, Hawkins ED, Sargent KM, et al. Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance. Cell Metab 2007;5: 167-79.
10. Boini KM, Zhang C, Xia M, Poklis JL, Li PL. Role of sphingolipid mediator ceramide in obesity and renal injury in mice fed a high-fat diet. J Pharmacol Exp Ther 2010;334: 839-46.
11. Langeveld M, Aerts JM. Glycosphingolipids and insulin resistance. Prog Lipid Res 2009;48: 196-205.
12. Böttner A, Kratzsch J, Müller G, Kapellen TM, Blüher S, et al. Gender differences of adiponectin levels develop during the progression of puberty and are related to serum androgen levels. J Clin Endocrinol Metab 2004;89: 4053-61.